[Systemic scleroderma].
Mori
S
S
Department of Dermatology, Gifu University School of Medicine.
Maeda
M
M
Matsubara
K
K
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002423:Cause of Death; D002648:Child; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007564:Japan / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012015:Reference Standards; D012595:Scleroderma, Systemic / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D012737:Sex Factors; D014810:Vitamin E / Q000627:therapeutic use
D002121:Calcium Channel Blockers; D007166:Immunosuppressive Agents; D014810:Vitamin E